GlassScriptPhysician profile
Terry Stephen Lowry
NPI 1932283082
$2,336.08
in general payments reported to CMS, 2019-2025
28 companies · $288 in 2025
The $288 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $173 · 2021: $231 · 2022: $377 · 2023: $552 · 2024: $458 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,297.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $363.43 | 2019-2023 | Ethicon, Echelon; Endopath, Harmonic |
| Inari Medical, INC. | $312.20 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $207.39 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $198.41 | 2019-2024 | |
| Medtronic, INC. | $192.75 | 2021-2025 | Mvp, In.Pact Admiral, Ellipsys Vascular Access System |
| Getinge USA Sales, LLC | $176.97 | 2020-2024 | Vasoview Hemopro 2, Cardioroot |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Angiodynamics, INC. | $100.00 | 2023-2024 | Auryon Laser System 100-120 Vac |
| Lemaitre Vascular, INC. | $94.68 | 2023-2025 | Hydro Lemaitre Valvulotome, Restoreflow |
| Bard Peripheral Vascular, INC. | $78.42 | 2020-2023 | Covera, Venovo |
| Chiesi USA, INC. | $68.50 | 2020-2021 | |
| Kls-Martin L.P. | $62.58 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $56.25 | 2024 | Keytruda |
| Abbott Laboratories | $52.03 | 2023 | Epic |
| Cardiovascular Systems INC. | $39.67 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $32.25 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $21.90 | 2019 | |
| Biomerieux INC | $21.10 | 2023 | Nephrocheck Liquid Control Kit |
| Bolton Medical INC | $16.82 | 2023 | Treo Abdominal Stent-Graft System |
| Cook Medical LLC | $16.11 | 2025 | Zenith Alpha |
| Next Science LLC | $15.44 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.61 | 2021 | |
| Edwards Lifesciences Corporation | $12.37 | 2021 | |
| Veran Medical Technologies, INC. | $12.32 | 2019 | |
| Baxter Healthcare | $12.15 | 2022 | |
| Amgen INC. | $12.06 | 2020 | |
| Olympus America INC. | $11.90 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Lowry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.